| |
| |
|
| Insider
Information: |
Young William D |
| Relationship: |
Director |
| City: |
Brisbane |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
573,414 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$8,365,662 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
573,414 |
|
|
| Total
Value |
$8,365,662 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Monogram Biosciences Inc |
134495-OLD |
Chairman and CEO, Dire... |
2008-05-09 |
361,810 |
2005-08-05 |
0 |
Premium* |
|
|
Innoviva Inc |
INVA |
Director |
2014-05-22 |
83,935 |
2008-04-22 |
0 |
Premium* |
|
|
Biomarin Pharmaceutical Inc |
BMRN |
Director |
2015-06-10 |
11,875 |
2011-05-12 |
0 |
Premium* |
|
|
Theravance Biopharma, Inc. |
TBPH |
|
2022-04-26 |
78,010 |
2015-04-22 |
0 |
Premium* |
|
|
Vertex Pharmaceuticals Inc |
VRTX |
Director |
2020-01-02 |
9,311 |
2016-06-01 |
0 |
Premium* |
|
|
Praxis Precision Medicines, Inc. |
PRAX |
Director |
2021-05-13 |
28,473 |
2021-05-13 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TBPH |
Theravance Biopharma, Inc... |
|
– • – |
2022-04-26 |
4 |
A |
$0.00 |
$0 |
D/D |
9,852 |
78,010 |
0 |
- |
|
| PRAX |
Praxis Precision Medicine... |
Director |
– • – |
2021-05-13 |
4 |
A |
$0.00 |
$0 |
D/D |
28,473 |
28,473 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
Director |
– • – |
2021-04-27 |
4 |
A |
$0.00 |
$0 |
D/D |
9,828 |
68,158 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
Director |
– • – |
2020-04-28 |
4 |
A |
$0.00 |
$0 |
D/D |
6,635 |
58,330 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2020-01-02 |
4 |
AS |
$217.72 |
$4,378,696 |
D/D |
(20,000) |
9,311 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2020-01-02 |
4 |
OE |
$72.14 |
$1,442,800 |
D/D |
20,000 |
29,311 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2019-12-30 |
4 |
AS |
$218.05 |
$6,562,715 |
D/D |
(30,000) |
9,311 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2019-12-30 |
4 |
OE |
$65.65 |
$1,969,500 |
D/D |
30,000 |
39,311 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2019-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
2,381 |
9,311 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
Director |
– • – |
2019-04-30 |
4 |
A |
$0.00 |
$0 |
D/D |
8,385 |
51,695 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2018-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,801 |
6,930 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
Director |
– • – |
2018-05-01 |
4 |
A |
$0.00 |
$0 |
D/D |
8,186 |
43,310 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2017-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
2,188 |
5,129 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
Director |
– • – |
2017-05-17 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
35,124 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2016-06-01 |
4 |
A |
$0.01 |
$29 |
D/D |
2,941 |
2,941 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
Director |
– • – |
2016-05-03 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
29,124 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2015-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
1,100 |
11,875 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
Director |
– • – |
2015-04-22 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
23,124 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2014-06-04 |
4 |
A |
$0.00 |
$0 |
D/D |
2,100 |
10,775 |
0 |
- |
|
| INVA |
Innoviva Inc |
Director |
– • – |
2014-05-22 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
83,935 |
0 |
- |
|
| INVA |
Innoviva Inc |
Director |
– • – |
2014-04-07 |
4 |
OE |
$9.69 |
$249,996 |
D/D |
25,806 |
77,935 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2013-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
3,400 |
8,675 |
0 |
- |
|
| INVA |
Innoviva Inc |
Director |
– • – |
2013-04-24 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
52,129 |
0 |
- |
|
| INVA |
Innoviva Inc |
Director |
– • – |
2012-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
46,129 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2012-05-08 |
4 |
A |
$0.00 |
$0 |
D/D |
3,400 |
5,275 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
